John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$257M |
| 2 |
Boston Scientific
BSX
|
+$228M |
| 3 |
Meta Platforms (Facebook)
META
|
+$225M |
| 4 |
Amazon
AMZN
|
+$220M |
| 5 |
S&P Global
SPGI
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$252M |
| 2 |
PayPal
PYPL
|
+$252M |
| 3 |
Walt Disney
DIS
|
+$217M |
| 4 |
Chevron
CVX
|
+$206M |
| 5 |
Best Buy
BBY
|
+$152M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.83% |
| 2 | Consumer Discretionary | 13.53% |
| 3 | Financials | 9.1% |
| 4 | Healthcare | 9.07% |
| 5 | Consumer Staples | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
DNOW Inc
DNOW
$2.85B
| $1.69M | ﹤0.01% |
235,835
-360,227
| -60% | -$2.03M |
|
1602
CALL
Sherwin-Williams
SHW
$85.1B
| $1.69M | ﹤0.01% |
+6,900
| New | +$1.64M |
|
1603
IMAX
IMAX
$2.96B
| $1.69M | ﹤0.01% |
93,735
+79,335
| +551% | +$1.09M |
|
|
NXGN
1604
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $1.69M | ﹤0.01% |
92,519
-73,268
| -44% | -$1.16M |
|
|
DSPG
1605
DELISTED
DSP Group Inc
DSPG
| $1.69M | ﹤0.01% |
101,732
-94,464
| -48% | -$1.45M |
|
|
LHCG
1606
CALL
DELISTED
LHC Group LLC
LHCG
| $1.69M | ﹤0.01% |
7,900
+4,000
| +103% | +$852K |
|
|
ZNGA
1607
PUT
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $1.69M | ﹤0.01% |
170,700
-59,400
| -26% | -$535K |
|
|
LADR
1608
Ladder Capital
LADR
$1.26B
| $1.68M | ﹤0.01% |
171,656
+106,138
| +162% | +$901K |
|
|
LAC
1609
DELISTED
Lithium Americas Corp. Common Shares
LAC
| $1.68M | ﹤0.01% |
+133,806
| New | +$1.5M |
|
1610
PDF Solutions
PDFS
$1.87B
| $1.68M | ﹤0.01% |
77,600
-10,926
| -12% | -$229K |
|
1611
CALL
Paycom
PAYC
$10.4B
| $1.67M | ﹤0.01% |
3,700
+2,000
| +118% | +$797K |
|
|
PLYM
1612
DELISTED
Plymouth Industrial REIT
PLYM
| $1.67M | ﹤0.01% |
111,542
+49,312
| +79% | +$659K |
|
1613
Gold Fields
GFI
$43.7B
| $1.67M | ﹤0.01% |
+179,701
| New | +$1.9M |
|
1614
PUT
HSBC
HSBC
$358B
| $1.66M | ﹤0.01% |
64,100
-80,300
| -56% | -$1.91M |
|
|
CXP
1615
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $1.65M | ﹤0.01% |
114,963
+68,473
| +147% | +$872K |
|
1616
PUT
Sturm, Ruger & Co
RGR
$613M
| $1.65M | ﹤0.01% |
25,300
-100
| -0.4% | -$6.43K |
|
|
AXDX
1617
DELISTED
Accelerate Diagnostics
AXDX
| $1.65M | ﹤0.01% |
21,700
+17,357
| +400% | +$1.55M |
|
1618
PUT
Ciena
CIEN
$54.9B
| $1.64M | ﹤0.01% |
31,100
+21,100
| +211% | +$938K |
|
1619
WillScot Mobile Mini Holdings
WSC
$3.85B
| $1.64M | ﹤0.01% |
70,886
-43,936
| -38% | -$886K |
|
1620
CALL
PENN Entertainment
PENN
$2.38B
| $1.64M | ﹤0.01% |
19,000
-51,400
| -73% | -$3.67M |
|
1621
PUT
D.R. Horton
DHI
$42.2B
| $1.64M | ﹤0.01% |
23,800
+6,600
| +38% | +$481K |
|
|
TRTX
1622
TPG RE Finance Trust
TRTX
$599M
| $1.63M | ﹤0.01% |
+153,902
| New | +$1.46M |
|
1623
Viking Therapeutics
VKTX
$3.99B
| $1.63M | ﹤0.01% |
290,220
+225,596
| +349% | +$1.37M |
|
1624
Gossamer Bio
GOSS
$100M
| $1.63M | ﹤0.01% |
168,855
-188,708
| -53% | -$1.86M |
|
1625
PUT
Hershey
HSY
$37.6B
| $1.63M | ﹤0.01% |
10,700
-2,500
| -19% | -$370K |
|
Similar funds
John Overdeck's Q4 2020 Portfolio in Review
As of Q4 2020, John Overdeck held 3,971 positions worth $34.9B, up 24% from $28.2B the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.
John Overdeck deployed $1.95B of net new capital in Q4 2020, opening 955 new positions and adding to 1,167 existing holdings. Its largest new stake was Boston Scientific: 6,312,819 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Chevron, an estimated $206M trimmed.
- John Overdeck's largest Q4 2020 buy was Boston Scientific: 6,312,819 shares worth $227M.
- John Overdeck added most to NVIDIA in Q4 2020, an estimated $257M increase.
- John Overdeck's biggest Q4 2020 reduction was Chevron, cutting an estimated $206M.
- John Overdeck fully exited Pfizer in Q4 2020, selling an estimated $252M.
- John Overdeck's ten largest holdings make up 7.4% of its $34.9B portfolio in Q4 2020.
- John Overdeck opened 955 new positions and closed 694 in Q4 2020.
- John Overdeck's portfolio value rose 24% quarter-over-quarter to $34.9B.
Based on Two Sigma Investments's 13F filing for Q4 2020, filed 16 Feb 2021.